RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.4061/2011/941310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|